INSP NYSE Week ended 24 Jul 2026

Weekly Investor Report

Inspire Medical Systems Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 49.19 USD
-2.8% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -14.8% below the Trend Line and sits at 9.5% of its 52-week range. The latest completed week returned -2.8%, after a 7.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 55/100 conviction, while the latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 2d.

Setup score 32 out of 100
Latest Close 49.19 USD 24 Jul 2026
1W Return -2.8% latest completed week
4W Return 7.6% short-term follow-through
12W Return -13.2% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -2.8% Latest completed week; four-week move 7.6%. Indicator stack 0/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 55/100 conviction; expected move 15.7%. News sentiment 51/100 69 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -14.8% below the Trend Line and sits at 9.5% of its 52-week range. The latest completed week returned -2.8%, after a 7.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1012-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.10Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.6% over four weeks, -13.2% over 12 weeks, and -61.8% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-2.8%
4W7.6%
12W-13.2%
26W-38.0%
52W-61.8%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.74Latest activity-pressure read.
Pressure change2519.6%Four-week change in activity pressure.
Leadership-37.79Latest relative-leadership reading.
RS change19.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength65/100Blend of value, momentum, and quality. Underlying universe rank 36; rank 1 is best.
Value73/100Relative valuation strength. Underlying universe rank 28; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth86/100Revenue and earnings growth. Underlying universe rank 15; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework32/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
10.8x
Price divided by trailing earnings.
Price / sales
1.5x
Market value relative to trailing revenue.
EV / EBITDA
16.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
13.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
85.8%
Gross profit retained from each unit of revenue.
Operating margin
7.0%
Operating profit retained from revenue.
Free-cash-flow margin
19.3%
Free cash flow generated from revenue.
Return on invested capital
6.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.9%
Latest one-year revenue growth.
EPS growth
97.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
17.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
6.5%
Net share repurchases relative to market value.
Shareholder yield
6.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

INSP shows bearish options pressure with a 55/100 conviction score, put-call volume ratio of 2.34, expected move of 15.7%, and Sharemaestro trend signal inactive.

Conviction55/100
Expected move15.7%
Put/call volume2.34
Pressure-52
Speculation27
Volatility45
Trend agreement87
Open options detail
Insider activity16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 69 relevant articles.

11 positive · 54 neutral · 4 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move15.7%Nearest-chain priced movement where available.
52-week drawdown-66.5%Distance below the 52-week high.
13-week volatility8.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher9 of 2617 weeks finished lower.
Best week+10.2%Week of 10 Jul.
Worst week-21.9%Week of 8 May.
Latest week-2.8%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains3
Flat weeks0
Modest losses8
Sharp losses9
Recent vol8.2%13-week weekly-return volatility.
Base vol10.8%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -6.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis17/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.10; No reversal markers Factors55/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 9; Small Cap Core rank 27 SVQF32/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 684.5 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options48/100

INSP shows bearish options pressure with a 55/100 conviction score, put-call volume ratio of 2.34, expected move of 15.7%, and Sharemaestro trend signal inactive.

Bearish · Put-side pressure · Expected move 15.7% Sentiment51/100

Weighted news tone is neutral across 69 relevant articles.

BlackRock (INSP) reports 4.16M Inspire Medical shares, 14.4% ownership stake Insiders16 / 4

16 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202649.19 USD-2.8%57.76 USD143.6 USD0.74-37.793.5MOff
17 Jul 202650.60 USD-2.2%59.30 USD145.2 USD0.77-37.923.6MOff
10 Jul 202651.76 USD10.2%60.84 USD146.8 USD0.50-38.945.7MOff
3 Jul 202646.95 USD2.7%63.47 USD148.6 USD0.17-45.194.0MOff
26 Jun 202645.72 USD7.3%66.46 USD150.3 USD-0.03-46.768.4MOff
19 Jun 202642.61 USD-0.2%69.08 USD152.1 USD-0.30-52.763.6MOff
12 Jun 202642.70 USD3.7%70.66 USD153.8 USD-0.26-53.454.1MOff
5 Jun 202641.19 USD-0.4%72.12 USD155.5 USD-0.27-55.925.3MOff
29 May 202641.36 USD-5.7%73.47 USD157.2 USD-0.20-57.954.6MOff
22 May 202643.84 USD9.5%74.49 USD159.0 USD-0.18-55.976.0MOff
15 May 202640.05 USD-9.5%75.62 USD160.6 USD-0.33-60.517.1MOff
8 May 202644.26 USD-21.9%76.88 USD162.3 USD-0.45-57.5011.1MOff
1 May 202656.70 USD0.7%77.91 USD163.9 USD-0.60-45.834.2MOff
24 Apr 202656.31 USD-2.2%78.57 USD165.3 USD-0.76-47.144.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.